key: cord-0970594-6lxebhxw authors: Tay, J. K.; Cross, G. B.; Lee, C. K.; Yan, B.; Loh, J.; Lim, Z. Y.; Ngiam, N.; Chee, J.; Gan, S. W.; Saraf, A.; Chow, W. T. E.; Goh, H. L.; Siow, C. H.; Lian, D. W.; Loh, W. S.; Loh, K. S.; Chow, V. T.; Wang, D. Y.; Fuh, J. Y.; Yen, C.-C.; Wong, J. E.; Allen, D. M. title: Design and clinical validation of a 3D-printed nasopharyngeal swab for COVID-19 testing date: 2020-06-20 journal: nan DOI: 10.1101/2020.06.18.20134791 sha: 29ae917846e5a797762397b71b29ddb66ce2b489 doc_id: 970594 cord_uid: 6lxebhxw We describe the development and validation of a novel 3D-printed nasopharyngeal swab for the identification of SARS-CoV-2. We subjected the novel swab to mechanical and fluid absorption testing ex-vivo, and confirmed its ability to retain and release murine coronavirus and SARS-CoV-2. Compared to the Copan FLOQSwab, the novel swab displayed excellent correlation of RT-PCR cycle threshold values on paired clinical testing in COVID-19 patients, at r = 0.918 and 0.943 for the SARS-CoV-2 ORF1/a and sarbecovirus E-gene respectively. Overall positive and negative percent agreement was 90.6% and 100% respectively on a dual-assay RT-PCR platform, with discordant samples observed only at high cycle thresholds. When carefully designed and tested, 3D-printed swabs are a viable alternative to traditional swabs and will help mitigate strained resources in the escalating COVID-19 pandemic. Since December 2019, the COVID-19 pandemic has spread to 188 countries, with 7.5 million cases worldwide and more than 400,000 fatalities. 1 One of the World Health Organization's strategic objectives is to control sporadic clusters and prevent community transmission by rapidly identifying all cases. 2 The identification of cases is typically performed using material collected from a nasopharyngeal swab, which is tested for SARS-CoV-2 using reverse transcriptase polymerase chain reaction (RT-PCR). With the surge in cases, testing for COVID-19 worldwide has been limited by shortages of critical components, including RNA extraction kits, PCR reagents, transport media and nasopharyngeal swabs. [3] [4] [5] Here, we share our experience in designing, testing, and clinically validating the utility of a non-flocked 3D printed nasopharyngeal swab for the identification of SARS-CoV-2. We first considered the clinical requirements of the swab, in relation to its mechanical, material and biological properties. In particular, while some friction is required to enhance the collection of material from the nasopharynx, sharp edges had to be avoided to avoid trauma and epistaxis. We thus designed the absorbent portion of the swab as a reinforced helix comprising outer blades and inward reverse blades to channel collected material into an internal reservoir ensuring sufficient cellular and extracellular matrix could be collected from the nasopharynx (Figure 1a,b) . We chose medical-grade resin polymer as the material and allowed flexibility up to 180 degrees to permit maneuverability within the All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . https://doi.org/10.1101/2020.06.18.20134791 doi: medRxiv preprint narrow nasopharyngeal space. Post-sterilization, the mechanical properties of the Python swab was tested and benchmarked against the FLOQSwab (Flexible Minitip Flocked Swab, COPAN Diagnostics Inc.). The Python swab had increased tensile strength and flexural strength compared to the FLOQSwab, and was able to tolerate torsional twisting of more than 800 degrees on itself (Figure 1c) . While its capacity to absorb fluids was inferior to the FLOQSwab, the Python swab was able to release a similar amount of fluid on testing with a roll plate approach (Figure 1d, Extended Data Figure 1 ). 6 As with other cytopathic viruses, SARS-CoV-2 invades and multiplies intracellularly, hence the ability of a swab to pick up cellular material is imperative. H&E smears obtained from Python swab samples demonstrate that the swab was able to collect sheets of epithelial cells (Figure 1e) . We confirmed the ability of the Python swab to retain and release viral samples by dipping swabs in spiked samples with standard inocula of murine coronavirus (mouse hepatitis virus, MHV) and SARS-CoV-2, resuspending in fresh viral transport medium, followed by viral RNA extraction and RT-PCR (Figure 1f ). We proceeded then to determine the clinical efficacy of the Python swab in comparison to the FLOQSwab, the standard swab used in our institution, via a case-control study of 40 patients diagnosed with COVID-19 by a positive SARS-CoV-2 RT-PCR test, and 10 control patients with acute respiratory illness who had tested negative for SARS-CoV-2. COVID-19 patients were swabbed at a median of day 8 of illness (range 2 -14 days). Participants had paired nasopharyngeal swabs through the same nostril performed by trained Infectious Disease and Otolaryngology doctors. The sequence of swabs was All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . https://doi.org/10.1101/2020.06.18.20134791 doi: medRxiv preprint randomized based on the sample number assigned to the participant, and the swab technique was standardized. All samples were tested at our institution's clinical laboratory using a RT-PCR dual assay for the SARS-CoV-2 ORF1/a and the sarbecovirus E-gene. Consistent with our laboratory protocols for clinical samples, samples positive for either of the gene targets were considered to have a confirmed diagnosis of COVID-19. With the FLOQSwab as the reference, we observed an overall positive percent agreement (PPA) and negative percent agreement (NPA) of the Python swab at 90.6% and 100%, with an overall agreement (OA) of 94% (Figure 2a) . None of the 10 control samples tested positive. Among 14 COVID-19 cases with swabs performed in the first week of illness, the overall agreement was 100%, while there were 3 false-negative cases out of 26 cases in the second week of illness (Figure 2b,c) . These 3 false-negative cases tested positive only for the E-gene (and not ORF1/a) on the FLOQSwab, and only at CT values > 37 (Figure 2d ,e). There were 4 discordant cases for the Python swab on the SARS-CoV-2 ORF1/a test alone, all of which were positive on the sarbecovirus E-gene for both swabs (Extended Data Figure 2 ). As such, the overall agreement was not affected by these cases in a dual-target testing strategy. We observed an excellent correlation of Ct values for both swabs, at r = 0.918 (p = 2.39e-12) and 0.943 (p = 6.46e-16) for the ORF1/a and E-gene respectively (Figure 2d, e) . We also observed that Ct values correlated positively with the day of illness, consistent with All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . https://doi.org/10.1101/2020.06.18.20134791 doi: medRxiv preprint a reduction in viral load as a patient recovers (Extended Data Figure 3 ). Mean Ct values for the Python swab were 1.33 and 1.40 higher than the FLOQSwab for the ORF1/a (28.72 vs 27.39, p = 0.0015) and E-gene (30.24 vs 28.84, p = 0.0037) respectively (Extended Data Figure 4) . No participant experienced frank epistaxis or swab breakage in this study. There was one episode of blood-stained mucous with the FLOQSwab, and one episode of mild giddiness after the Python swab. There was no difference in mean pain score between the Python swab and FLOQSwab (2.6 vs 2.5, p = 0.72, Figure 2f ). In terms of comfort, 23 participants (46%) felt no difference between both swabs, 16 (32%) felt that the FLOQSwab more comfortable, while 11 (22%) felt that the Python swab was more comfortable. Overall, 40 participants (80%) found both swabs acceptable, 6 (12%) preferred not to have the FLOQSwab, while 4 (8%) preferred not to have the Python swab. The accuracy of COVID-19 identification using nasopharyngeal swabs is dependent on a variety of factors, including patient's viral burden in the nasopharynx, swabbing technique as well as laboratory assays used for testing. This is reflected in a recent meta-analysis showed a pooled sensitivity of RT-PCR testing at 89%, but with a wide range of sensitivities from 50 -100% between studies. 7 Although the Python swab had marginally higher Ct values, suggesting that it picked up less material than the FLOQSwab, the overall agreement between both swabs was All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . https://doi.org/10.1101/2020.06.18.20134791 doi: medRxiv preprint excellent. It is likely that such small differences in Ct values did not have significant impact on the accuracy of RT-PCR testing, which is highly sensitive for small amounts of material. A strength of our study design is that it allowed us to robustly evaluate the swab by sampling cases with a wide spectrum of viral loads, including those at the limits of detection. Other 3D printed polymer swab designs have been evaluated on COVID-19 cases at diagnosis with false-negative cases observed even at low Ct values of < 25. 8 In contrast, the false-negative cases in our study had high Ct values (37.48 -38.12) and were identified only in the second week of disease, these may represent recovering cases with low or no infectivity. Indeed, all three cases were discharged to community care facilities 1 -4 days after the study swab was performed. A recent study demonstrated that virus could not be isolated in cell culture from patients who had E-gene Ct values ≥ 34, suggesting a lack of infectivity. 9 Another study observed cell culture infectivity only at Ct values < 24 and < 8 days of illness. 10 Similarly, in a multicenter cohort of 73 COVID-19 patients in Singapore, no viable virus could be isolated in cell culture when the Ct value was 30 or higher. 11 Here we show that with careful design and testing, non-flocked 3D-printed polymer swabs can be highly accurate. The Python swab is safe and acceptable for patient use. It is a viable alternative to traditional swabs and will help mitigate strained resources in the escalating COVID-19 pandemic. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . https://doi.org/10.1101/2020.06.18.20134791 doi: medRxiv preprint Nasopharyngeal (NP) swabs should capture respiratory epithelial cells and mucus (cellular-mucus matrix), retain the cellular-mucus matrix while relaying the swab to a transport container, then release the cellular-mucus matrix into the transport media from which viral RNA can be detected in order to be effective. Intuitively, the greater the surface area of the NP swab, the greater the cellular-mucus matrix volume captured and released, with resultant increased sensitivity of the assay. With that goal in mind and with awareness of the diameter of the nasal passage through which the NP swab must journey, a square shaped, helix design with a reservoir concept was selected. The helix makes 1.5 turns from start to end. This allows for surface manipulation (sculpting, flexing and weaving) while retaining sufficient structural integrity for withstanding pushing and turning impact forces. The gaps between the helix blades and the offset of the blades' inner aspects allow the swab to collect the cellular-mucus matrix via capillary effect and deposit it into the central reservoir. The cellular-mucus matrix contained within the reservoir and adherent to the swab tip is released when the NP swab tip is submerged and agitated in viral transport media. The 3D printed swabs were designed and developed using Rhino 6 for Windows (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. For tensile testing, swabs were gripped at 10mm from end of the tip. Torsional testing was performed by gripping the swab at 12.7mm from both ends and at a torsional speed of 8 rpm in a clockwise twisting direction. The resulting number of turns (in degrees) when the specimen breaks was reported. Two types of medium were used for the testing, including the Universal Viral Transport Medium (Becton, Dickinson and Company, MD, USA #220527) and a viscous fluid that mimics the human mucus 12 -25% (w/v) Pluronic F127 aqueous solution (Sigma Aldrich #P2443), the viscosity of which ranges from 0.6-24 Pa at 20℃ from an internal pre-test. Fluid (3ml) was transferred to a 15ml centrifuge tube, which was then weighted using an All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . https://doi.org/10.1101/2020.06.18.20134791 doi: medRxiv preprint analytical balances (Sartorius Entris, Göttingen, Germany). The swab was immersed in the fluid for 5 -10 seconds. The tube was weighted again after removing the swab for the calculation of the absorbed liquid, which is the difference between the weight of the tube before swab immersion and after removing the immersed swab. Two release methods were performed after fluid absorption, including vortex approach and roll plate approach. The vortex approach is a commonly used procedure to mix an experimental sample and diluent. 13 An empty 15ml centrifuge tube was weighted; after the immersed swab was placed into the tube, it was vortexed on a lab vortex mixer (Vortex Genie 2, model #G-560, Scientific Industries, USA) for 5 sec. The swab was then removed and the tube was weighted again; the difference of the tube weights represents the release liquid. The roll plate approach provides a semi moisture environment that is frequently used in laboratory and clinical testing for swabs. 6 A swab was weighted before the absorption. After the absorption procedure, the swab was transferred and rolled with exerting downward pressure on a 1.5% agar plate (Sigma Aldrich #05040); the swab tip was rolled back and forth across the agar surface. Then, the swab was weighted again. The difference of the weight of the swab before and after the roll plate procedure was used as the release weight of liquid. The volumes of the absorption and release were calculated using the weights and the density of the two liquids, which were 0.00103 g/µl (universal viral transport media) and 0.00102 g/µl (viscous fluid) from an internal pre-test. The experiment was repeated three times for each composition of the swab types, liquids, and release methods. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. Between May 11 and May 12, 2020, we prospectively recruited 40 adults with a laboratory-confirmed diagnosis of COVID-19 admitted to a tertiary healthcare institution in Singapore. Only adults aged between 21 -90 years with a nasopharyngeal swab All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . https://doi.org/10.1101/2020.06.18.20134791 doi: medRxiv preprint positive for SARS-CoV-2 on RT-PCR were eligible. Patients with known bleeding diathesis were excluded. 10 adults admitted for acute respiratory illness tested to be negative for SARS-CoV-2 were recruited as controls. All participants were recruited with informed consent, and the study was approved by the Institutional Review Board of the National Healthcare Group, Singapore (Approval number: DSRB 2020/00464). All parts of the study were performed in compliance with the Human Biomedical Research Act, Singapore. Demographic information such as age, gender and race, as well as day of illness was recorded. Participants were subjected to two consecutive nasopharyngeal swabs in the same nostril using the COPAN FLOQSwab (Becton, Dickinson and Company, MD, USA #220527) and the novel Python swab. Participants assigned an even case number received the FLOQSwab first, followed by the Python swab, while the reverse was true for participants assigned with an odd case number. Swabs were performed in full PPE (personal protective equipment) by trained Infectious Disease or Otolaryngology doctors who routinely administer nasopharyngeal swab testing in our institution during the COVID-19 pandemic. For each participant, both swabs were administered by the same doctor. The number of turns for each swab was standardized at five to ten 360 o rotations, with consistency in number of rotations between both swabs emphasized during the study initiation briefing. Immediately after each swab was taken, it was placed into 3ml of BD Universal Viral Transport media (Becton, Dickinson and Company, MD, USA #220527) typically used for FLOQSwabs. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . https://doi.org/10.1101/2020.06.18.20134791 doi: medRxiv preprint All COVID-19 cases were swabbed within the first 14 days of onset of symptoms. A copy of the study protocol is available in the supplementary information accompanying this article. While the study protocol allowed for either nasopharyngeal swabs or oropharyngeal swabs to be performed, this was standardized to only nasopharyngeal swabs for consistency. Immediately after the swabs were administered, the pain score, as well as any adverse events including epistaxis and nausea, were specifically recorded for each swab. An acceptability questionnaire was then administered recording the participant's perception of comfort and discomfort between the swabs, as well as acceptability for future testing. All swabs were tested for SARS-CoV-2 virus using the cobas SARS-CoV-2 test which is a dual-target qualitative real-time RT-PCR assay for use on the high-throughput automated cobas 6800 System (Roche Molecular Systems, Inc., Branchburg, NJ), according to the manufacturer's instructions. Briefly, 600 µL of the universal transport media was transferred to a secondary tube for automated sample preparation (nucleic acid extraction and PCR amplification) on the cobas 6800. Positive and negative controls were included in each run. The assay targets the ORF1ab (nonstructural protein) sequence which is specific to SARS-CoV-2 and the E gene (envelope protein) sequence which is highly conserved among sarbecoviruses. Following the manufacturer guidelines All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. Positive and negative percent agreement were calculated for each RT-PCR target based on 2 x 2 contingency tables, using the categorical results from the FLOQSwab as the All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. Paired Student's t-test was used to compare the mean Ct values and pain score between both swabs. P-values less than or equal to 0.05 were considered as significant. Bland-Altman plots were prepared using the paired.plotBA function from the R package: Paired Data Analysis (PairedData), v1.1.1. The data shown in the manuscript is available upon request from the corresponding author. The source code to reproduce the clinical statistical analysis is made available at https://github.com/josh-tay/COVID-19_Python_swab. support in sterilizing the Python swabs. We are grateful to Dr. Ho Chaw Sing and the National Additive Manufacturing Innovation Cluster (NAMIC) Singapore, for their coordinating efforts between stakeholders and regulatory agencies. Images of the final swab were also contributed by Eye-2-Eye Communications and Structo. Data from the mechanical testing was kindly provided by TÜV SÜD PSB Singapore. This study was supported in part by the National Medical Research Council, Singapore (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . https://doi.org/10.1101/2020.06.18.20134791 doi: medRxiv preprint The National University of Singapore is in the process of licensing out fabrication of nasopharyngeal swabs to commercial entities, based on the Python swab described here and has filed for patent protection, together with CCY and WTEC. All clinical aspects of the study (clinical testing, analysis and interpretation) were performed independently from the swab design team, including CCY and WTEC. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. a (a,b) and the E-gene (c,d). Red line represents line of best fit in a linear model. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . https://doi.org/10.1101/2020.06.18.20134791 doi: medRxiv preprint Extended Data Figure 4 . Bland-Altman plots for the comparison of Ct values between paired positive swabs for the ORF1/a (a) and E-gene (b) respectively. The horizontal axis shows the mean Ct value for each pair of swabs, while the vertical axis shows the difference in Ct value between the swabs (Ct value for Python swab -Ct value for FLOQSwab). The mean difference (+1.33 for ORF1/a and +1.40 for E-gene) is represented by the blue bar and the shaded area represents the boundaries of the 95% confidence interval. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted June 20, 2020. . https://doi.org/10.1101/2020.06.18.20134791 doi: medRxiv preprint An interactive web-based dashboard to track COVID-19 in real time Novel Coronoavirus: Strategic Preparedness and Response Plan Evaluation of COVID-19 RT-qPCR test in multi-sample pools Large-scale, in-house production of viral transport media to support SARS-CoV-2 PCR testing in a multi-hospital healthcare network during the COVID-19 pandemic Comparison of Copan Eswab and FLOQswab for COVID-19 Open Development and Clinical Validation Of Multiple 3D-Printed Nasopharyngeal Collection Swabs: Rapid Resolution of a Critical COVID-19 Testing Bottleneck Viral RNA load as determined by cell culture as a management tool for discharge of SARS-CoV-2 patients from infectious disease wards + 01221 $*%%% 01221 %* Extended Data Figure 1. Fluid release and absorption. a-b, Fluid absorption and release for the FLO-QSwab and Python swab for (a) universal viral transport media (UVTM) and (b) viscous fluid (25% w/v Pluronic F127 aqueous solution), tested using the vortex approach. c-d, Fluid absorption and release for the FLOQSwab and Python swab for (c) UVTM and (d) viscous fluid, tested using the roll plate approach. () %*"+% ( + 01221 $*%%% 01221 %* We acknowledge the support of our medical colleagues and patient participants during the clinical study, as well as the National University Hospital Operating Theatre for their All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted June 20, 2020. Figure 2 . Clinical comparison of Python swab and FLOQSwab. a-c, Categorical results for (a) all participants, (b) COVID-19 cases in the first week of illness, and (c) COVID-19 cases in the second week of illness. d-e, Correlation plots for all COVID-19 cases that tested positive for ORF1/a (d) and E-gene (e) on RT-PCR. Red line represents line of best fit (linear model). Blue dots represent positive cases that were not identified by the Python swab on ORF1/a, but were identified by the Python swab on E-gene. f, Pain score for both swabs, red bar represents the mean for each swab. All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.